Morgan Stanley’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,022
| Closed | -$29 | – | 8090 |
|
|
2024
Q2 | $29 | Sell |
1,022
-718,026
| -100% | -$20.4K | ﹤0.01% | 7686 |
|
|
2024
Q1 | $64.7K | Sell |
719,048
-719,088
| -50% | -$64.7K | ﹤0.01% | 6127 |
|
|
2023
Q4 | $151K | Buy |
1,438,136
+719,268
| +100% | +$75.7K | ﹤0.01% | 6044 |
|
|
2023
Q3 | $162K | Hold |
718,868
| – | – | ﹤0.01% | 5678 |
|
|
2023
Q2 | $188K | Hold |
718,868
| – | – | ﹤0.01% | 5671 |
|
|
2023
Q1 | $129K | Hold |
718,868
| – | – | ﹤0.01% | 5904 |
|
|
2022
Q4 | $144K | Sell |
718,868
-400
| -0.1% | -$80 | ﹤0.01% | 5805 |
|
|
2022
Q3 | $518K | Hold |
719,268
| – | – | ﹤0.01% | 5252 |
|
|
2022
Q2 | $381K | Hold |
719,268
| – | – | ﹤0.01% | 5549 |
|
|
2022
Q1 | $633K | Hold |
719,268
| – | – | ﹤0.01% | 5270 |
|
|
2021
Q4 | $1.61M | Buy |
719,268
+1,001
| +0.1% | +$2.24K | ﹤0.01% | 4736 |
|
|
2021
Q3 | $2.44M | Buy |
+718,267
| New | +$2.44M | ﹤0.01% | 4404 |
|